We are currently experiencing a “renaissance” in psychedelic research, as Michael Pollan writes in a recent issue of The New Yorker. Hallucinogenic drugs like psilocybin can be used to treat a range of mental health disorders, from anxiety and addiction to depression, and researchers at the nation’s leading medical schools are studying their full therapeutic potential.
The New Yorker: “Between 1953 and 1973, the federal government spent four million dollars to fund a hundred and sixteen studies of LSD, involving more than seventeen hundred subjects. (These figures don’t include classified research.)
“Psychedelics were tested on alcoholics, people struggling with obsessive-compulsive disorder, depressives, autistic children, schizophrenics, terminal cancer patients, and convicts, as well as on perfectly healthy artists and scientists (to study creativity) and divinity students (to study spirituality). The results reported were frequently positive…”